Tapping Into Top Partnering Opportunities Beyond The Blockbuster
Executive Summary
The upcoming Therapeutic Area Partnership conference will showcase companies in niche areas that are prime targets for partnerships or acquisitions.
You may also be interested in...
Big Pharma Lays Off Fewer Sales Reps In 2013
Pharmaceutical sales forces have taken a huge hit over the last few years as the industry reorganizes and shifts its priorities. Yet, experts believe that pharma companies will begin hiring reps back in coming years as they believe more new drugs will be approved.
Partnering Door Opens For Sarepta With 48-Week Data In Hand
Sarepta Therapeutics’ positive data on its lead muscular dystrophy drug eteplirsen puts the company in a strong position at the partnering table and sets the stage for a neck and neck race with GSK/Prosensa to bring the first treatment for the rare disease to market.
P&G Spinout Spins Off Another Company, While Looking To Partner Mid-Stage Oral Anemia Candidate
Akebia will sell off, partner or possibly bring AKB-6548 – thought to be a safer erythropoietin stimulator than currently available injectables – through Phase III, while its spinout, Aerpio, will focus on clinical development of candidates for diabetic macular edema and inflammatory bowel disease.